{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T14:18:03Z","timestamp":1781187483350,"version":"3.54.1"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T00:00:00Z","timestamp":1748649600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T00:00:00Z","timestamp":1748649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antonie van Leeuwenhoek"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s10482-025-02094-9","type":"journal-article","created":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T10:54:07Z","timestamp":1748688847000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Overview of the Q fever vaccine development: current status and future prospects"],"prefix":"10.1007","volume":"118","author":[{"given":"Samira","family":"Karimaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safoura","family":"Moradkasani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saber","family":"Esmaeili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,31]]},"reference":[{"key":"2094_CR1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1196\/annals.1355.026","volume":"1063","author":"M Andoh","year":"2005","unstructured":"Andoh M et al (2005) Comparative virulence of phase I and II Coxiella burnetii in immunodeficient mice. Ann N Y Acad Sci 1063:167\u2013170","journal-title":"Ann N Y Acad Sci"},{"issue":"7","key":"2094_CR2","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1128\/IAI.01767-06","volume":"75","author":"M Andoh","year":"2007","unstructured":"Andoh M et al (2007) T cells are essential for bacterial clearance, and gamma interferon, tumor necrosis factor alpha, and B cells are crucial for disease development in Coxiella burnetii infection in mice. Infect Immun 75(7):3245\u20133255","journal-title":"Infect Immun"},{"key":"2094_CR3","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s10096-012-1750-3","volume":"32","author":"E Angelakis","year":"2013","unstructured":"Angelakis E et al (2013) Q fever and pregnancy: disease, prevention, and strain specificity. Eur J Clin Microbiol Infect Dis 32:361\u2013368","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"35","key":"2094_CR4","doi-asserted-by":"publisher","first-page":"4392","DOI":"10.1016\/j.vaccine.2005.04.010","volume":"23","author":"N Arricau-Bouvery","year":"2005","unstructured":"Arricau-Bouvery N et al (2005) Effect of vaccination with phase I and phase II Coxiella burnetii vaccines in pregnant goats. Vaccine 23(35):4392\u20134402","journal-title":"Vaccine"},{"issue":"11","key":"2094_CR5","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nri2868","volume":"10","author":"MF Bachmann","year":"2010","unstructured":"Bachmann MF, Jennings GT (2010) Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat Rev Immunol 10(11):787\u2013796","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"2094_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0205882","volume":"13","author":"LA Baeten","year":"2018","unstructured":"Baeten LA et al (2018) Standardized guinea pig model for Q fever vaccine reactogenicity. PLoS ONE 13(10):e0205882","journal-title":"PLoS ONE"},{"key":"2094_CR7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ijfoodmicro.2019.05.010","volume":"303","author":"JF Barandika","year":"2019","unstructured":"Barandika JF et al (2019) Viable Coxiella burnetii in hard cheeses made with unpasteurized milk. Int J Food Microbiol 303:42\u201345","journal-title":"Int J Food Microbiol"},{"issue":"10","key":"2094_CR8","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/j.vaccine.2021.01.062","volume":"39","author":"BU Bauer","year":"2021","unstructured":"Bauer BU et al (2021) Humoral immune response to Q fever vaccination of three sheep flocks naturally pre-infected with Coxiella burnetii. Vaccine 39(10):1499\u20131507","journal-title":"Vaccine"},{"issue":"33","key":"2094_CR9","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.1016\/j.vaccine.2023.06.061","volume":"41","author":"BU Bauer","year":"2023","unstructured":"Bauer BU et al (2023) Humoral and cellular immune responses in sheep following administration of different doses of an inactivated phase I vaccine against Coxiella burnetii. Vaccine 41(33):4798\u20134807","journal-title":"Vaccine"},{"key":"2094_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.894536","volume":"13","author":"P Binette","year":"2022","unstructured":"Binette P et al (2022) Murine Q fever vaccination model reveals sex dimorphism in early phase delayed-type hypersensitivity responses. Front Immunol 13:894536","journal-title":"Front Immunol"},{"issue":"1","key":"2094_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4049\/jimmunol.1601775","volume":"199","author":"PN Boyaka","year":"2017","unstructured":"Boyaka PN (2017) Inducing mucosal IgA: a challenge for vaccine adjuvants and delivery systems. J Immunol 199(1):9\u201316","journal-title":"J Immunol"},{"issue":"38","key":"2094_CR12","doi-asserted-by":"publisher","first-page":"13832","DOI":"10.1073\/pnas.0406035101","volume":"101","author":"DG Brockstedt","year":"2004","unstructured":"Brockstedt DG et al (2004) Listeria-based cancer vaccines that segregate immunogenicity from toxicity. Proc Natl Acad Sci 101(38):13832\u201313837","journal-title":"Proc Natl Acad Sci"},{"key":"2094_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0065-2776(06)91001-3","volume":"91","author":"A Casadevall","year":"2006","unstructured":"Casadevall A, Pirofski LA (2006) A reappraisal of humoral immunity based on mechanisms of antibody-mediated protection against intracellular pathogens. Adv Immun 91:1\u201344","journal-title":"Adv Immun"},{"issue":"4","key":"2094_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/iai.00504-17","volume":"86","author":"R Cherla","year":"2018","unstructured":"Cherla R et al (2018) Coxiella burnetii inhibits neutrophil apoptosis by exploiting survival pathways and antiapoptotic protein Mcl-1. Infect Immun 86(4):10\u20131128. https:\/\/doi.org\/10.1128\/iai.00504-17","journal-title":"Infect Immun"},{"issue":"2","key":"2094_CR15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/vaccines13020151","volume":"13","author":"M Christodoulou","year":"2025","unstructured":"Christodoulou M, Papagiannis D (2025) Q Fever Vaccines: Unveiling the Historical Journey and Contemporary Innovations in Vaccine Development. Vaccines (Basel). 13(2):151","journal-title":"Vaccines (Basel)."},{"key":"2094_CR16","volume-title":"Washington","author":"Council, N.R., Committee on Special Immunizations Program for Laboratory Personnel Engaged in Research on Countermeasures for Select Agents. Protecting the Frontline in Biodefense Research: The Special Immunizations Program","year":"2011","unstructured":"Council, N.R., Committee on Special Immunizations Program for Laboratory Personnel Engaged in Research on Countermeasures for Select Agents. Protecting the Frontline in Biodefense Research: The Special Immunizations Program (2011) Washington. National Academies Press, DC"},{"issue":"5","key":"2094_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/cti.2016.22","volume":"5","author":"JK Dowling","year":"2016","unstructured":"Dowling JK, Mansell A (2016) Toll-like receptors: the swiss army knife of immunity and vaccine development. Clinical Trans Immun 5(5):e85","journal-title":"Clinical Trans Immun"},{"key":"2094_CR18","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.3389\/fmicb.2019.02022","volume":"10","author":"J Dresler","year":"2019","unstructured":"Dresler J et al (2019) Quantitative proteome profiling of Coxiella burnetii reveals major metabolic and stress differences under axenic and cell culture cultivation. Front Microbiol 10:2022","journal-title":"Front Microbiol"},{"issue":"1","key":"2094_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1128\/CMR.00045-16","volume":"30","author":"C Eldin","year":"2017","unstructured":"Eldin C et al (2017) From Q fever to Coxiella burnetii infection: a paradigm change. Clin Microbiol Rev 30(1):115\u2013190","journal-title":"Clin Microbiol Rev"},{"issue":"12","key":"2094_CR20","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.1128\/IAI.00973-13","volume":"81","author":"A Elliott","year":"2013","unstructured":"Elliott A, Peng Y, Zhang G (2013) Coxiella burnetii interaction with neutrophils and macrophages in vitro and in SCID mice following aerosol infection. Infect Immun 81(12):4604\u20134614","journal-title":"Infect Immun"},{"key":"2094_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetimm.2024.110840","volume":"277","author":"G Ferrara","year":"2024","unstructured":"Ferrara G et al (2024) Evaluation of the phase-specific antibody response in water buffalo (Bubalus bubalis) after two doses of an inactivated phase I Coxiella burnetii vaccine. Vet Immunol Immunopathol 277:110840","journal-title":"Vet Immunol Immunopathol"},{"issue":"7","key":"2094_CR22","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1128\/JCM.36.7.1823-1834.1998","volume":"36","author":"P-E Fournier","year":"1998","unstructured":"Fournier P-E, Marrie TJ, Raoult D (1998) Diagnosis of Q fever. J Clin Microbiol 36(7):1823\u20131834","journal-title":"J Clin Microbiol"},{"key":"2094_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.653092","volume":"12","author":"AP Fratzke","year":"2021","unstructured":"Fratzke AP et al (2021a) Subunit vaccines using TLR triagonist combination adjuvants provide protection against Coxiella burnetii while minimizing reactogenic responses. Front Immunol 12:653092","journal-title":"Front Immunol"},{"key":"2094_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.754712","volume":"12","author":"AP Fratzke","year":"2021","unstructured":"Fratzke AP et al (2021b) Coxiella burnetii whole cell vaccine produces a Th1 delayed-type hypersensitivity response in a novel sensitized mouse model. Front Immunol 12:754712","journal-title":"Front Immunol"},{"key":"2094_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.886810","volume":"13","author":"AP Fratzke","year":"2022","unstructured":"Fratzke AP, van Schaik EJ, Samuel JE (2022a) Immunogenicity and reactogenicity in Q fever vaccine development. Front Immunol 13:886810","journal-title":"Front Immunol"},{"issue":"6","key":"2094_CR26","first-page":"703","volume":"10","author":"V Genig","year":"1965","unstructured":"Genig V (1965a) Experience in mass immunization of humans with the M-44 live vaccine against Q-fever. 2. Skin and oral routes of immunization. Vopr Virusol 10(6):703\u2013707","journal-title":"Vopr Virusol"},{"key":"2094_CR27","unstructured":"Genig, V., et al., (1966) Experience on the mass immunization of humans with the M-44 live vaccine against q-fever. rept. I. Subcutaneous Method of Immunization."},{"issue":"8","key":"2094_CR28","doi-asserted-by":"publisher","first-page":"4488","DOI":"10.4049\/jimmunol.169.8.4488","volume":"169","author":"E Ghigo","year":"2002","unstructured":"Ghigo E et al (2002) Coxiella burnetii survival in THP-1 monocytes involves the impairment of phagosome maturation: IFN-\u03b3 mediates its restoration and bacterial killing. J Immunol 169(8):4488\u20134495","journal-title":"J Immunol"},{"issue":"1","key":"2094_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1365-2567.2011.03517.x","volume":"135","author":"SC Gilbert","year":"2012","unstructured":"Gilbert SC (2012) T-cell-inducing vaccines\u2013what\u2019s the future. Immunology 135(1):19\u201326","journal-title":"Immunology"},{"issue":"3","key":"2094_CR30","doi-asserted-by":"publisher","first-page":"611","DOI":"10.4049\/jimmunol.1900991","volume":"204","author":"AP Gilkes","year":"2020","unstructured":"Gilkes AP et al (2020) Tuning subunit vaccines with novel TLR triagonist adjuvants to generate protective immune responses against Coxiella burnetii. J Immunol 204(3):611\u2013621","journal-title":"J Immunol"},{"key":"2094_CR31","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3389\/fvets.2017.00208","volume":"4","author":"D Gonz\u00e1lez-Barrio","year":"2017","unstructured":"Gonz\u00e1lez-Barrio D, Ortiz JA, Ruiz-Fons F (2017) Estimating the efficacy of a commercial phase i inactivated vaccine in decreasing the prevalence of coxiella burnetii infection and shedding in red deer (cervus elaphus). Front Vet Sci 4:208","journal-title":"Front Vet Sci"},{"issue":"2","key":"2094_CR32","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1080\/21645515.2019.1697110","volume":"16","author":"P Gonzalez-Dias","year":"2020","unstructured":"Gonzalez-Dias P et al (2020) Methods for predicting vaccine immunogenicity and reactogenicity. Hum Vaccin Immunother 16(2):269\u2013276","journal-title":"Hum Vaccin Immunother"},{"issue":"9","key":"2094_CR33","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.3390\/vaccines10091393","volume":"10","author":"SR Graves","year":"2022","unstructured":"Graves SR et al (2022) An O-specific polysaccharide\/tetanus toxoid conjugate vaccine induces protection in guinea pigs against virulent challenge with Coxiella burnetii. Vaccines 10(9):1393","journal-title":"Vaccines"},{"key":"2094_CR34","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00178-19","author":"A Gregory","year":"2019","unstructured":"Gregory A et al (2019) Coxiella burnetii intratracheal aerosol infection model in mice, guinea pigs, and nonhuman primates. Infect Immun. https:\/\/doi.org\/10.1128\/iai.00178-19","journal-title":"Infect Immun"},{"issue":"12","key":"2094_CR35","doi-asserted-by":"publisher","first-page":"100461","DOI":"10.1016\/j.xcrm.2021.100461","volume":"2","author":"AE Gregory","year":"2021","unstructured":"Gregory AE et al (2021) Soluble antigens derived from Coxiella burnetii elicit protective immunity in three animal models without inducing hypersensitivity. Cell Reports Medicine 2(12):100461","journal-title":"Cell Reports Medicine"},{"issue":"1\u20132","key":"2094_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vetmic.2010.10.007","volume":"149","author":"R Guatteo","year":"2011","unstructured":"Guatteo R et al (2011) Prevalence of Coxiella burnetii infection in domestic ruminants: a critical review. Vet Microbiol 149(1\u20132):1\u201316","journal-title":"Vet Microbiol"},{"key":"2094_CR37","volume":"23","author":"R Hammami","year":"2021","unstructured":"Hammami R et al (2021) Q Fever Presenting as Myocarditis Idcases 23:e01056","journal-title":"Q Fever Presenting as Myocarditis Idcases"},{"issue":"2","key":"2094_CR38","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1128\/iai.31.2.641-645.1981","volume":"31","author":"RC Humphres","year":"1981","unstructured":"Humphres RC, Hinrichs DJ (1981) Role of antibody in Coxiella burnetii infection. Infect Immun 31(2):641\u2013645","journal-title":"Infect Immun"},{"issue":"4","key":"2094_CR39","doi-asserted-by":"publisher","first-page":"800","DOI":"10.4269\/ajtmh.12-0653","volume":"89","author":"A Islam","year":"2013","unstructured":"Islam A et al (2013) The attenuated nine mile phase II clone 4\/RSA439 strain of Coxiella burnetii is highly virulent for severe combined immunodeficient (SCID) mice. Am J Trop Med Hyg 89(4):800","journal-title":"Am J Trop Med Hyg"},{"key":"2094_CR40","doi-asserted-by":"publisher","first-page":"1192821","DOI":"10.3389\/fimmu.2023.1192821","volume":"14","author":"S Jan","year":"2023","unstructured":"Jan S et al (2023) Multivalent vaccines demonstrate immunogenicity and protect against Coxiella burnetii aerosol challenge. Front Immunol 14:1192821","journal-title":"Front Immunol"},{"key":"2094_CR41","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.micpath.2018.11.012","volume":"126","author":"A Jaydari","year":"2019","unstructured":"Jaydari A, Forouharmehr A, Nazifi N (2019) Determination of immunodominant scaffolds of Com1 and OmpH antigens of Coxiella burnetii. Microb Pathog 126:298\u2013309","journal-title":"Microb Pathog"},{"issue":"10\u201311","key":"2094_CR42","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.humimm.2020.05.010","volume":"81","author":"A Jaydari","year":"2020","unstructured":"Jaydari A, Nazifi N, Forouharmehr A (2020) Computational design of a novel multi-epitope vaccine against Coxiella burnetii. Hum Immunol 81(10\u201311):596\u2013605","journal-title":"Hum Immunol"},{"issue":"6","key":"2094_CR43","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1093\/infdis\/135.6.995","volume":"135","author":"JW Johnson","year":"1977","unstructured":"Johnson JW et al (1977) Lesions in guinea pigs infected with Coxiella burnetii strain M-44. J Infect Dis 135(6):995\u2013998","journal-title":"J Infect Dis"},{"issue":"5","key":"2094_CR44","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1128\/JCM.03221-13","volume":"52","author":"LM Kampschreur","year":"2014","unstructured":"Kampschreur LM et al (2014) Chronic Q fever in the Netherlands 5 years after the start of the Q fever epidemic: results from the Dutch chronic Q fever database. J Clin Microbiol 52(5):1637\u20131643","journal-title":"J Clin Microbiol"},{"key":"2094_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bcp.2016.05.001","volume":"120","author":"CP Karch","year":"2016","unstructured":"Karch CP, Burkhard P (2016) Vaccine technologies: From whole organisms to rationally designed protein assemblies. Biochem Pharmacol 120:1\u201314","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"2094_CR46","first-page":"389","volume":"60","author":"J Kaz\u00e1r","year":"1982","unstructured":"Kaz\u00e1r J et al (1982) Immunogenicity and reactogenicity of a Q fever chemovaccine in persons professionally exposed to Q fever in Czechoslovakia. Bull World Health Organ 60(3):389\u2013394","journal-title":"Bull World Health Organ"},{"issue":"1","key":"2094_CR47","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1196\/annals.1355.018","volume":"1063","author":"J Kazar","year":"2005","unstructured":"Kazar J (2005) Coxiella burnetii infection. Ann N Y Acad Sci 1063(1):105\u2013114","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"2094_CR48","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1186\/s12879-023-08904-7","volume":"23","author":"M Kodori","year":"2023","unstructured":"Kodori M, Amani J, Ahmadi A (2023) Unveiling promising immunogenic targets in Coxiella burnetii through in silico analysis: paving the way for novel vaccine strategies. BMC Infect Dis 23(1):902","journal-title":"BMC Infect Dis"},{"key":"2094_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.754690","volume":"12","author":"V Kumaresan","year":"2021","unstructured":"Kumaresan V et al (2021a) The feasibility of using Coxiella burnetii avirulent nine mile phase II viable bacteria as a live attenuated vaccine against Q fever. Front Immunol 12:754690","journal-title":"Front Immunol"},{"key":"2094_CR50","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1080\/21505594.2019.1575715","volume":"10","author":"C Long","year":"2019","unstructured":"Long C et al (2019) Comparative virulence of diverse Coxiella burnetii strains. Virulence 10:133\u2013150","journal-title":"Virulence"},{"issue":"1","key":"2094_CR51","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41541-021-00296-6","volume":"6","author":"CM Long","year":"2021","unstructured":"Long CM et al (2021) Contributions of lipopolysaccharide and the type IVB secretion system to Coxiella burnetii vaccine efficacy and reactogenicity. NPJ Vaccines 6(1):38","journal-title":"NPJ Vaccines"},{"issue":"8417\u20138418","key":"2094_CR52","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/S0140-6736(84)91617-9","volume":"324","author":"B Marmion","year":"1984","unstructured":"Marmion B et al (1984a) Vaccine prophylaxis of abattoir-associated Q fever. The Lancet 324(8417\u20138418):1411\u20131414","journal-title":"The Lancet"},{"issue":"8417\u20138418","key":"2094_CR53","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/S0140-6736(84)91617-9","volume":"2","author":"BP Marmion","year":"1984","unstructured":"Marmion BP et al (1984b) Vaccine prophylaxis of abattoir-associated Q fever. Lancet 2(8417\u20138418):1411\u20131414","journal-title":"Lancet"},{"issue":"2","key":"2094_CR54","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jaci.2017.12.971","volume":"141","author":"MM McNeil","year":"2018","unstructured":"McNeil MM, DeStefano F (2018) Vaccine-associated hypersensitivity. J Allergy Clinical Immun 141(2):463\u2013472","journal-title":"J Allergy Clinical Immun"},{"issue":"5","key":"2094_CR55","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.immuni.2022.04.013","volume":"55","author":"RC Mettelman","year":"2022","unstructured":"Mettelman RC, Allen EK, Thomas PG (2022) Mucosal immune responses to infection and vaccination in the respiratory tract. Immunity 55(5):749\u2013780","journal-title":"Immunity"},{"key":"2094_CR56","doi-asserted-by":"publisher","DOI":"10.1128\/genomea.00471-17","author":"JA Millar","year":"2017","unstructured":"Millar JA et al (2017) Whole-genome sequence of Coxiella burnetii Nine Mile RSA439 (phase II, clone 4), a laboratory workhorse strain. Genome Announc. https:\/\/doi.org\/10.1128\/genomea.00471-17","journal-title":"Genome Announc"},{"issue":"3","key":"2094_CR57","doi-asserted-by":"publisher","first-page":"404","DOI":"10.4049\/jimmunol.92.3.404","volume":"92","author":"RA Ormsbee","year":"1964","unstructured":"Ormsbee RA et al (1964) The influence of phase on the protective potency of Q fever vaccine. J Immunol 92(3):404\u2013412","journal-title":"J Immunol"},{"issue":"10","key":"2094_CR58","doi-asserted-by":"publisher","first-page":"4909","DOI":"10.4049\/jimmunol.1201622","volume":"189","author":"Y Peng","year":"2012","unstructured":"Peng Y et al (2012) Development of a lipopolysaccharide-targeted peptide mimic vaccine against Q fever. J Immunol 189(10):4909\u20134920","journal-title":"J Immunol"},{"issue":"9","key":"2094_CR59","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1021\/acs.bioconjchem.3c00317","volume":"34","author":"A Ramirez","year":"2023","unstructured":"Ramirez A et al (2023) Engineering Protein Nanoparticles Functionalized with an Immunodominant Coxiella burnetii Antigen to Generate a Q Fever Vaccine. Bioconjug Chem 34(9):1653\u20131666","journal-title":"Bioconjug Chem"},{"issue":"4","key":"2094_CR60","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S1473-3099(05)70052-9","volume":"5","author":"D Raoult","year":"2005","unstructured":"Raoult D, Marrie T, Mege J (2005) Natural history and pathophysiology of Q fever. Lancet Infect Dis 5(4):219\u2013226","journal-title":"Lancet Infect Dis"},{"key":"2094_CR61","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.2217\/fmb-2023-0117","volume":"18","author":"P Redden","year":"2023","unstructured":"Redden P et al (2023) Q fever - immune responses and novel vaccine strategies. Future Microbiol 18:1185\u20131196","journal-title":"Future Microbiol"},{"issue":"12","key":"2094_CR62","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1080\/21645515.2017.1371377","volume":"13","author":"PM Reeves","year":"2017","unstructured":"Reeves PM et al (2017) Q-vaxcelerate: A distributed development approach for a new Coxiella burnetii vaccine. Hum Vaccin Immunother 13(12):2977\u20132981","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"2094_CR63","first-page":"226","volume":"68","author":"A Rekiki","year":"2004","unstructured":"Rekiki A, Bouakane A, Rodolakis A (2004) Combined vaccination of live 1B Chlamydophila abortus and killed phase I Coxiella burnetii vaccine does not destroy protection against chlamydiosis in a mouse model. Can J Vet Res 68(3):226\u2013228","journal-title":"Can J Vet Res"},{"issue":"1","key":"2094_CR64","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1749-6632.2009.04511.x","volume":"1166","author":"A Rodolakis","year":"2009","unstructured":"Rodolakis A (2009) Q fever in dairy animals. Ann N Y Acad Sci 1166(1):90\u201393","journal-title":"Ann N Y Acad Sci"},{"key":"2094_CR65","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3389\/fmicb.2014.00726","volume":"5","author":"S Ruiz","year":"2014","unstructured":"Ruiz S, Wolfe DN (2014) Vaccination against Q fever for biodefense and public health indications. Front Microbiol 5:726","journal-title":"Front Microbiol"},{"issue":"11","key":"2094_CR66","doi-asserted-by":"publisher","first-page":"6085","DOI":"10.1128\/IAI.00763-06","volume":"74","author":"KE Russell-Lodrigue","year":"2006","unstructured":"Russell-Lodrigue KE et al (2006) Clinical and pathologic changes in a guinea pig aerosol challenge model of acute Q fever. Infect Immun 74(11):6085\u20136091","journal-title":"Infect Immun"},{"issue":"1","key":"2094_CR67","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41541-023-00727-6","volume":"8","author":"G Sam","year":"2023","unstructured":"Sam G et al (2023) Q fever immunology: the quest for a safe and effective vaccine. NPJ Vaccines 8(1):133","journal-title":"NPJ Vaccines"},{"issue":"1","key":"2094_CR68","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1017\/S0950268811000136","volume":"140","author":"B Schimmer","year":"2012","unstructured":"Schimmer B et al (2012) Low seroprevalence of Q fever in The Netherlands prior to a series of large outbreaks. Epidemiol Infect 140(1):27\u201335","journal-title":"Epidemiol Infect"},{"issue":"1","key":"2094_CR69","first-page":"79","volume":"267","author":"N Schmeer","year":"1987","unstructured":"Schmeer N et al (1987) Q fever vaccines for animals. Zentralbl Bakteriol Mikrobiol Hyg A 267(1):79\u201388","journal-title":"Zentralbl Bakteriol Mikrobiol Hyg A"},{"issue":"12","key":"2094_CR70","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.1128\/IAI.00694-16","volume":"84","author":"L Schoenlaub","year":"2016","unstructured":"Schoenlaub L et al (2016) Coxiella burnetii avirulent nine mile phase II induces caspase-1-dependent pyroptosis in murine peritoneal B1a B cells. Infect Immun 84(12):3638\u20133654","journal-title":"Infect Immun"},{"key":"2094_CR71","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3389\/fimmu.2019.00207","volume":"10","author":"A Scholzen","year":"2019","unstructured":"Scholzen A et al (2019) Promiscuous Coxiella burnetii CD4 epitope clusters associated with human recall responses are candidates for a novel T-cell targeted multi-epitope Q fever vaccine. Front Immunol 10:207","journal-title":"Front Immunol"},{"key":"2094_CR72","doi-asserted-by":"publisher","unstructured":"Scholzen, A., et al., Coxiella burnetii epitope-specific T-cell responses in patients with chronic Q fever. Infection and Immunity, 2019. 87(10): p. https:\/\/doi.org\/10.1128\/iai. 00213\u201319.","DOI":"10.1128\/iai"},{"issue":"4","key":"2094_CR73","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3390\/vaccines6040083","volume":"6","author":"E Sellens","year":"2018","unstructured":"Sellens E et al (2018) Frequency of adverse events following Q fever immunisation in young adults. Vaccines 6(4):83","journal-title":"Vaccines"},{"key":"2094_CR74","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s12026-008-8059-4","volume":"43","author":"JG Shannon","year":"2009","unstructured":"Shannon JG, Heinzen RA (2009) Adaptive immunity to the obligate intracellular pathogen Coxiella burnetii. Immunol Res 43:138\u2013148","journal-title":"Immunol Res"},{"issue":"24","key":"2094_CR75","doi-asserted-by":"publisher","first-page":"8722","DOI":"10.1073\/pnas.0501863102","volume":"102","author":"JG Shannon","year":"2005","unstructured":"Shannon JG, Howe D, Heinzen RA (2005) Virulent Coxiella burnetii does not activate human dendritic cells: role of lipopolysaccharide as a shielding molecule. Proc Natl Acad Sci 102(24):8722\u20138727","journal-title":"Proc Natl Acad Sci"},{"key":"2094_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2024.107136","volume":"198","author":"A Sharma","year":"2025","unstructured":"Sharma A et al (2025) Computational studies on metabolic pathways of Coxiella burnetii to combat Q fever: A roadmap to vaccine development. Microb Pathog 198:107136","journal-title":"Microb Pathog"},{"key":"2094_CR77","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.actatropica.2019.03.022","volume":"194","author":"R Shome","year":"2019","unstructured":"Shome R et al (2019) Coxiella seroprevalence and risk factors in large ruminants in Bihar and Assam. India Acta Tropica 194:41\u201346","journal-title":"India Acta Tropica"},{"issue":"1","key":"2094_CR78","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1093\/oxfordjournals.aje.a120618","volume":"84","author":"RW Sidwell","year":"1966","unstructured":"Sidwell RW, Gebhardt LP (1966) Studies of Latent Q fever infections. III. effects of parturition upon latently infected guinea pigs and white mice. Am J Epidemiol 84(1):132\u2013137","journal-title":"Am J Epidemiol"},{"key":"2094_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.901372","volume":"13","author":"AE Sluder","year":"2022","unstructured":"Sluder AE et al (2022) Evaluation of a Human T Cell-Targeted Multi-Epitope Vaccine for Q Fever in Animal Models of Coxiella burnetii Immunity. Front Immunol 13:901372","journal-title":"Front Immunol"},{"issue":"1","key":"2094_CR80","first-page":"71","volume":"47","author":"JE Smadel","year":"1948","unstructured":"Smadel JE, Snyder MJ, Robbins FC (1948) Vaccination against Q fever. Am J Hyg 47(1):71\u201381","journal-title":"Am J Hyg"},{"issue":"4","key":"2094_CR81","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.tibtech.2018.10.004","volume":"37","author":"JK Tom","year":"2019","unstructured":"Tom JK et al (2019) Applications of immunomodulatory immune synergies to adjuvant discovery and vaccine development. Trends Biotechnol 37(4):373\u2013388","journal-title":"Trends Biotechnol"},{"issue":"1","key":"2094_CR82","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41541-023-00607-z","volume":"8","author":"S Tomaiuolo","year":"2023","unstructured":"Tomaiuolo S et al (2023) QuilA\u00ae adjuvanted Coxevac\u00ae sustains Th1-CD8(+)-type immunity and increases protection in Coxiella burnetii-challenged goats. NPJ Vaccines 8(1):17","journal-title":"NPJ Vaccines"},{"issue":"8","key":"2094_CR83","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nrmicro3049","volume":"11","author":"EJ Van Schaik","year":"2013","unstructured":"Van Schaik EJ et al (2013) Molecular pathogenesis of the obligate intracellular bacterium Coxiella burnetii. Nat Rev Microbiol 11(8):561\u2013573","journal-title":"Nat Rev Microbiol"},{"key":"2094_CR84","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fcimb.2017.00025","volume":"7","author":"EJ Van Schaik","year":"2017","unstructured":"Van Schaik EJ et al (2017) The SCID mouse model for identifying virulence determinants in Coxiella burnetii. Front Cell Infect Microbiol 7:25","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"2094_CR85","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1080\/07853890.2017.1407035","volume":"50","author":"V Vetter","year":"2018","unstructured":"Vetter V et al (2018) Understanding modern-day vaccines: what you need to know. Ann Med 50(2):110\u2013120","journal-title":"Ann Med"},{"issue":"4","key":"2094_CR86","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1111\/j.1462-5822.2007.00901.x","volume":"9","author":"DE Voth","year":"2007","unstructured":"Voth DE, Heinzen RA (2007) Lounging in a lysosome: the intracellular lifestyle of Coxiella burnetii. Cell Microbiol 9(4):829\u2013840","journal-title":"Cell Microbiol"},{"issue":"16","key":"2094_CR87","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1016\/S0264-410X(97)00107-2","volume":"15","author":"DM Waag","year":"1997","unstructured":"Waag DM, England MJ, Pitt ML (1997) Comparative efficacy of a Coxiella burnetii chloroform:methanol residue (CMR) vaccine and a licensed cellular vaccine (Q-Vax) in rodents challenged by aerosol. Vaccine 15(16):1779\u20131783","journal-title":"Vaccine"},{"issue":"19\u201320","key":"2094_CR88","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1016\/S0264-410X(02)00176-7","volume":"20","author":"DM Waag","year":"2002","unstructured":"Waag DM et al (2002) Comparative efficacy and immunogenicity of Q fever chloroform: methanol residue (CMR) and phase I cellular (Q-Vax) vaccines in cynomolgus monkeys challenged by aerosol. Vaccine 20(19\u201320):2623\u20132634","journal-title":"Vaccine"},{"issue":"4","key":"2094_CR89","first-page":"374","volume":"50","author":"CL Wilhelmsen","year":"2000","unstructured":"Wilhelmsen CL, Waag DM (2000) Guinea pig abscess\/hypersensitivity model for study of adverse vaccination reactions induced by use of Q fever vaccines. Comp Med 50(4):374\u2013378","journal-title":"Comp Med"},{"key":"2094_CR90","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/j.1749-6632.1990.tb42243.x","volume":"590","author":"JC Williams","year":"1990","unstructured":"Williams JC et al (1990) Antigenic structure of Coxiella burnetii. A comparison of lipopolysaccharide and protein antigens as vaccines against Q fever. Ann N Y Acad Sci 590:370\u2013380","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"2094_CR91","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3390\/vaccines11030511","volume":"11","author":"SE Williams-Macdonald","year":"2023","unstructured":"Williams-Macdonald SE et al (2023) Efficacy of phase I and phase II Coxiella burnetii bacterin vaccines in a pregnant ewe challenge model. Vaccines 11(3):511","journal-title":"Vaccines"},{"issue":"1","key":"2094_CR92","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087206","volume":"9","author":"X Xiong","year":"2014","unstructured":"Xiong X et al (2014) Exploratory study on Th1 epitope-induced protective immunity against Coxiella burnetii infection. PLoS ONE 9(1):e87206","journal-title":"PLoS ONE"},{"issue":"10","key":"2094_CR93","first-page":"1580","volume":"215","author":"X Xiong","year":"2017","unstructured":"Xiong X et al (2017) Identification of Coxiella burnetii CD8+ T-cell epitopes and delivery by attenuated Listeria monocytogenes as a vaccine vector in a C57BL\/6 mouse model. J Infect Dis 215(10):1580\u20131589","journal-title":"J Infect Dis"},{"issue":"6","key":"2094_CR94","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1111\/zph.12871","volume":"68","author":"II Zendoia","year":"2021","unstructured":"Zendoia II et al (2021) Analysis of environmental dust in goat and sheep farms to assess Coxiella burnetii infection in a Q fever endemic area: Geographical distribution, relationship with human cases and genotypes. Zoonoses Public Health 68(6):666\u2013676","journal-title":"Zoonoses Public Health"},{"issue":"10","key":"2094_CR95","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.micinf.2007.05.008","volume":"9","author":"LA Zenewicz","year":"2007","unstructured":"Zenewicz LA, Shen H (2007) Innate and adaptive immune responses to Listeria monocytogenes: a short overview. Microbes Infect 9(10):1208\u20131215","journal-title":"Microbes Infect"},{"issue":"3","key":"2094_CR96","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1080\/21645515.2015.1103405","volume":"12","author":"Y Zeng","year":"2016","unstructured":"Zeng Y et al (2016) Generation of human MHC (HLA-A11\/DR1) transgenic mice for vaccine evaluation. Hum Vaccin Immunother 12(3):829\u2013836","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"2094_CR97","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/cmi.2017.92","volume":"15","author":"L Zhang","year":"2018","unstructured":"Zhang L (2018) Multi-epitope vaccines: a promising strategy against tumors and viral infections. Cell Mol Immunol 15(2):182\u2013184","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"2094_CR98","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/j.1749-6632.2003.tb07420.x","volume":"990","author":"G Zhang","year":"2003","unstructured":"Zhang G, Samuel J (2003) Identification and cloning potentially protective antigens of Coxiella burnetii using sera from mice experimentally infected with Nine Mile phase I. Ann N Y Acad Sci 990(1):510\u2013520","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"2094_CR99","doi-asserted-by":"publisher","first-page":"8372","DOI":"10.4049\/jimmunol.179.12.8372","volume":"179","author":"G Zhang","year":"2007","unstructured":"Zhang G et al (2007) Mechanisms of vaccine-induced protective immunity against Coxiella burnetii infection in BALB\/c mice. J Immunol 179(12):8372\u20138380","journal-title":"J Immunol"},{"issue":"11","key":"2094_CR100","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1586\/14760584.2015.1081067","volume":"14","author":"L Zhang","year":"2015","unstructured":"Zhang L, Wang W, Wang S (2015) Effect of vaccine administration modality on immunogenicity and efficacy. Expert Rev Vaccines 14(11):1509\u20131523","journal-title":"Expert Rev Vaccines"}],"container-title":["Antonie van Leeuwenhoek"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10482-025-02094-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10482-025-02094-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10482-025-02094-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T15:02:27Z","timestamp":1751295747000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10482-025-02094-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,31]]},"references-count":100,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["2094"],"URL":"https:\/\/doi.org\/10.1007\/s10482-025-02094-9","relation":{},"ISSN":["0003-6072","1572-9699"],"issn-type":[{"value":"0003-6072","type":"print"},{"value":"1572-9699","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,31]]},"assertion":[{"value":"14 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All of the authors declare that there are no financial or non-financial conflicting interests that are directly or indirectly related to the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"85"}}